AlfAccurate Advisors and Arham Yuva Seva Group Support 108 Dialysis Patients Under CSR Initiative

Mumbai, February 23, 2026: AlfAccurate Advisors Pvt. Ltd., in partnership with Arham Yuva Seva Group (AYSG), has implemented a CSR initiative titled “Arham Dialysis Sahay” to support individuals undergoing dialysis treatment for chronic kidney disease.

The programme extended assistance worth ₹20 lakh to 108 patients. Financial aid was provided through verified cheque support, allowing beneficiaries to continue dialysis treatment at medical centres of their choice. In addition to treatment support, grocery kits containing essential food items were distributed to help families manage daily expenses associated with ongoing healthcare needs.

Blood pressure monitoring devices were also provided to enable regular health tracking, along with trolley bags to assist patients in carrying medical supplies.

Chronic kidney disease requires recurring dialysis, often leading to significant financial strain. Annual treatment expenses can reach up to ₹1.5 lakh, resulting in interruptions in care for economically vulnerable patients. The initiative aims to reduce the financial burden associated with long-term treatment.

Arham Yuva Seva Group managed beneficiary identification, verification, and on-ground implementation through its volunteer network.

Mr. Rajesh Kothari, Founder & Managing Director, AlfAccurate Advisors, said, “Our CSR philosophy focuses on creating sustainable impact by supporting healthcare access and easing the burden on families facing long term medical challenges. We sincerely thank Arham Yuva Seva Group for their noble initiative.”

The initiative reflects a collaborative approach to providing healthcare support for patients requiring sustained medical treatment.